| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
1976-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1978-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46a96c6557aabcc2cabfcb07dcd2778
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb5dc764f5d544362907ad534c890a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b3cc2eeaeb0975d711af87262b70664 |
| publicationDate |
1978-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4089952-A |
| titleOfInvention |
Neuropsychotropic agents and their use |
| abstract |
Norgestrel, its D- and L-enantiomers and their 17-esters exhibit neuropsychotropic activity when administered in effective dosages to patients exhibiting neuropsychic disturbances of the affective and behavioral type. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4507290-A |
| priorityDate |
1975-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |